Toggle navigation
Browse
Home
People
Departments & Colleges
Research
Research Area Overlaps
Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib
Article (Web of Science)
International Collaboration
Overview
Research
Additional Document Info
View All
Overview
cited authors
Nemunaitis, John; Bauer, Sebastian; Blay, Jean-Yves; Choucair, Khalil; Gelderblom, Hans; George, Suzanne; Schoffski, Patrick; von Mehren, Margaret; Zalcberg, John; Achour, Haroun; Ruiz-Soto, Rodrigo; Heinrich, Michael C.
publication date
January 1, 2020
webpage
Web of Science
published in
FUTURE ONCOLOGY
Journal
Research
category
ONCOLOGY
Category
keywords
DCC-2618
KIT
PDGFRA
Phase III trial
gastrointestinal stromal tumor
receptor tyrosine kinase
ripretinib
sarcoma
targeted therapy
tyrosine kinase inhibitor
Additional Document Info
start page
4251
end page
4264
volume
16
issue
1